# Study to Investigate the Optimal Dose of Org 36286 to Induce Monofollicular Ovulation in Women With WHO Group II Anovulatory Infertility (P07016)

> **NCT00702585** · PHASE2 · COMPLETED · sponsor: **Organon and Co** · enrollment: 55 (actual)

## Conditions studied

- Infertility

## Interventions

- **DRUG:** Org 36286
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00702585
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-08-01
- **Primary completion:** 2002-10-15
- **Final completion:** 2002-10-15
- **Target enrollment:** 55 (ACTUAL)
- **Last updated:** 2024-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00702585

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00702585, "Study to Investigate the Optimal Dose of Org 36286 to Induce Monofollicular Ovulation in Women With WHO Group II Anovulatory Infertility (P07016)". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT00702585. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*